Ambrx Biopharma OverviewAmbrx Biopharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for AMAM.
Quarterly EBIT
-$25.49M
↓ 193.99% YoY
As of Sep 30, 2023
Annual EBIT (TTM)
-$70.79M
↑ 3.02% YoY
Trailing 12 months ending Sep 30, 2023
Ambrx Biopharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for AMAM.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023